Portsmouth CORE-D Routine Care Data Repository
NCT04983082 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 750000
Last updated 2026-06-29
Summary
An integrated database of depersonalised routine hospital patient data consisting of demographic and disease attributes, physiological or laboratory measurements, care contacts and interventions along with associated clinical outcomes. The database is an essential resource for the development and testing of risk models and classification systems, modified as necessary for patient subgroups, which can then be introduced into clinical care to improve patient outcomes. It can also be used for large scale simulations to evaluate interventions.
Conditions
- Adult Hospital Patients at Risk of Adverse Outcomes
Sponsors & Collaborators
-
Portsmouth Hospitals NHS Trust
lead OTHER_GOV
Principal Investigators
-
Paul E Schmidt, MRCP · Portsmouth Hospitals NHS Trust
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-08-19
- Primary Completion
- 2031-04-30
- Completion
- 2031-04-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Developing a Simple Test to Diagnose Overactive Bladder
NCT05572918 ·Status: UNKNOWN
-
Prevalence and Risk Factors Nocturnal Polyuria in Female OAB
NCT03810027 ·Status: COMPLETED
-
Comparison Between Desmopressin and Fesoterodine for Treatment of Night Time Voiding in Women Aged 65 and Older
NCT02262936 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Dose-Finding Study To Evaluate The Efficacy, Tolerability And Safety Of Fesoterodine In Comparison To Placebo For Overactive Bladder.
NCT00561951 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Trial to Investigate the Efficacy and Safety of Desmopressin for the Treatment of Nocturia in Adult Women
NCT01684800 ·Status: COMPLETED ·Phase: PHASE2
-
Trial Investigating the Long Term Safety and Tolerability of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Subjects
NCT03051009 ·Status: COMPLETED ·Phase: PHASE3
-
Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE)
NCT01786967 ·Status: COMPLETED ·Phase: PHASE3
-
Special Investigation For Long Term Use Of Tolterodine (Regulatory Post Marketing Commitment Plan).
NCT00795509 ·Status: COMPLETED
-
Clinical Trial of Desmopressin on Nocturia in Obstructive Sleep Apnoea Patients
NCT01530451 ·Status: TERMINATED ·Phase: PHASE3
-
Diversity in Patients With OAB
NCT05903105 ·Status: NOT_YET_RECRUITING
-
Pilot Trial in Sleep Laboratory Setting to Compare the Physiology of Night Time Bladder Function in Subjects With Overactive Bladder (OAB) Versus Subjects That Have Insomnia and Healthy Normal Subjects
NCT01029015 ·Status: COMPLETED
-
Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women
NCT03807024 ·Status: COMPLETED
-
Bladder Diary for Diagnosing Bladder Oversensitivity
NCT04981015 ·Status: COMPLETED
-
An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults
NCT00615836 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Persistence Among Patients With Overactive Bladder: A Retrospective Secondary Data Analysis in Asia Oceania
NCT03602508 ·Status: COMPLETED
-
A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)
NCT01099345 ·Status: TERMINATED
-
Long Term Study To Evaluate the Safety, Tolerability and Efficacy of Fesoterodine for Overactive Bladder.
NCT00658684 ·Status: COMPLETED ·Phase: PHASE3
-
A Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder in Taiwan, Korea and China
NCT03572231 ·Status: COMPLETED
-
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
NCT00780832 ·Status: TERMINATED ·Phase: NA
-
Trial of Desmopressin Orally Disintegrating Tablets (ODT) for Nocturia Due to Nocturnal Polyuria in Japanese Female Subjects
NCT02905682 ·Status: COMPLETED ·Phase: PHASE3
-
VA106483 and Alpha Blocker Interaction Study in Elderly Males
NCT00879216 ·Status: COMPLETED ·Phase: PHASE1
-
Local, Open-Label, Extension Trial Of The Efficacy And Safety Of Fesoterodine In Elderly Patients With Overactive Bladder
NCT01054222 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Link Between Bladder Sensation and Changes in Skin Electrical Conductance and Heart Rate.
NCT00481728 ·Status: COMPLETED ·Phase: PHASE1
-
Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years
NCT00857896 ·Status: COMPLETED ·Phase: PHASE2
-
Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary
NCT01552343 ·Status: COMPLETED ·Phase: PHASE3